v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

PREVALENCE OF HEPATITIS B AND HEPATITIS C CARRIER STATE AMONG HEALTHY BLOOD DONORS

AUTHORS:

Dr Muhammad Usman Zia, Dr Aqsa Aslam, Dr Saira Arshad

ABSTRACT:

In our population, hepatitis B and C has been increasing. Due to these viral infections, thousands of people have subjected to death. Objectives: Prevalence of hepatitis b and hepatitis c carrier state among healthy blood donors. Subject and Methods: The current research study was organized at Rahim Yar Khan from the time period allocated to this study was from January 2013 to August 2018. Methods: The people enrolled for this study were healthy and young blood donors. By employing ict screening kits, these participants were screened for HBSAG and anti-HIV. Monthly reports of Blood Donors were collected from Blood transfusion units and data was assembled from these reports. Results: Total people selected for this study were 2,17,847. These people were healthy young donors. All participants were screened for HBV and HCV. Out of total, the number of people who were noticed positive for HBsAg and anti-HCV were 5143(2.4%) and 6407(2.2%) respectively.2,03,522 people were screened at the District level. The number of subjects out of total that were found positive for HBsAg and anti-HCV were 4449(2.2%) respectively. Total 14,325 subjects were screened at Tehsil Units. From these, the subjects positive for HBsAG were 624(4.8%) and those who were positive for anti-HCV were 789(5.5%). Conclusion: The study concluded that as compare to surrounding rural areas of district Rahim Yar Khan, the occurrence of HBV and HCV is low in urban areas. Moreover, among healthy blood donors, the incidence of HBV and HCV infection is high. Key Words: Hepatitis B Virus, Hepatitis C Virus, HBsAG, Anti-HCV, Blood Donors.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.